Skip to main content
Robin Deterding, MD, Pediatric Pulmonology, Aurora, CO

RobinDeterdingMD

Pediatric Pulmonology Aurora, CO

Professor of Pediatrics, University Colorado

Dr. Deterding is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Deterding's full profile

Already have an account?

  • Office

    13123 E 16th Ave
    Aurora, CO 80045
    Phone+1 720-777-1234

Education & Training

  • University of Colorado
    University of ColoradoFellowship, Pediatric Pulmonology, 1990 - 1993
  • Southern Illinois University
    Southern Illinois UniversityResidency, Internal Medicine, 1986 - 1990
  • Southern Illinois University School of Medicine
    Southern Illinois University School of MedicineClass of 1986

Certifications & Licensure

  • CO State Medical License
    CO State Medical License 1990 - 2025
  • IL State Medical License
    IL State Medical License 1986 - 1990
  • American Board of Pediatrics Pediatric Pulmonology

Awards, Honors, & Recognition

  • Career Teaching Scholar University of Colorado Department of Pediatrics, 2016
  • Ed and Roxanne Fie Anderson Family Endowed Chair for Breathing Children's Hospital Colorado, 2016
  • James E Strain Children’s Colorado Clinician Award Children's Hospital Colorado, 2016
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Novel Application of Aptamer Proteomic Analysis in Cystic Fibrosis Bronchoalveolar Lavage Fluid  
    Scott D Sagel, Robin R Deterding, Emily M DeBoer, Jonathan Popler, Edith T Zemanick, Frank J Accurso, PROTEOMICS – Clinical Applications

Press Mentions

  • Anesthesia-Free Procedure Widens Scope of Patients Eligible for Diagnostic Tool
    Anesthesia-Free Procedure Widens Scope of Patients Eligible for Diagnostic ToolApril 19th, 2023
  • Ofev Shows Good Safety Profile in Children with Fibrosing ILDs
    Ofev Shows Good Safety Profile in Children with Fibrosing ILDsSeptember 13th, 2022
  • New Data from Boehringer Ingelheim Support the Potential Use of Nintedanib in Children and Adolescents with Fibrosing Interstitial Lung Disease
    New Data from Boehringer Ingelheim Support the Potential Use of Nintedanib in Children and Adolescents with Fibrosing Interstitial Lung DiseaseSeptember 6th, 2022
  • Join now to see all

Grant Support

  • Educational CoreNational Heart, Lung, And Blood Institute2005–2008

Committees

  • Board of Directors, CU medicine 2016 - 2017

Professional Memberships